CEN BIOTECH INC (CENBF) is a publicly traded company in the Unknown sector. Across all available filings, 10 corporate insiders have executed 135 transactions totaling $997.9K, demonstrating a bearish sentiment with -$997.9K in net insider flow. The most recent transaction on Dec 6, 2021 involved a transaction of 2,500,000 shares valued at $0.
No significant insider buying has been recorded for CENBF in the recent period.
No significant insider selling has been recorded for CENBF in the recent period.
Based on recent SEC filings, insider sentiment for CENBF is bearish with an Insider Alignment Score of 0/100 and a net flow of -$997.9K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at CEN BIOTECH INC (CENBF) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 10 insiders are actively trading CENBF stock, having executed 135 transactions in the past 90 days. The most active insider is Bahige B. Chaaban (Executive), who has made 9 transactions totaling $796.5K.
Get notified when executives and directors at CENBF file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 6, 2021 | Leigh Purdy Rick | Executive | Award | 2,500,000 | $N/A | $0 | |
| Jun 25, 2021 | Tarrabain Alex | Executive | Award | 1,000,000 | $N/A | $0 | |
| Jun 16, 2021 | Tarrabain Alex | Executive | Other | 3,000 | $N/A | $0 | |
| May 16, 2021 | Tarrabain Alex | Executive | Other | 3,000 | $N/A | $0 | |
| Apr 16, 2021 | Tarrabain Alex | Executive | Other | 3,000 | $N/A | $0 | |
| Apr 10, 2021 | Tarrabain Alex | Executive | Conversion | 30,000 | $1.60 | $48.0K | |
| Apr 2, 2021 | Tarrabain Alex | Executive | Award | 300,000 | $N/A | $0 | |
| Apr 2, 2021 | Ferris Ameen | Executive | Award | 1,000,000 | $N/A | $0 | |
| Apr 2, 2021 | B. Chaaban Bahige | Executive | Award | 3,106,122 | $N/A | $0 | |
| Apr 2, 2021 | Payne Brian | Executive | Award | 1,435,000 | $N/A | $0 | |
| Apr 2, 2021 | Boswell Richard | Executive | Award | 2,185,679 | $N/A | $0 | |
| Apr 2, 2021 | Saadikh Usamakh | Executive | Award | 1,000,000 | $N/A | $0 | |
| Apr 2, 2021 | Strilchuck Donald | Executive | Award | 341,250 | $N/A | $0 | |
| Apr 2, 2021 | Lavenu Harold Andre Aubrey De | Executive | Award | 1,041,250 | $N/A | $0 | |
| Mar 16, 2021 | Tarrabain Alex | Executive | Other | 3,000 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 16 | $997.9K | 95.4% |
Conversion(C) | 1 | $48.0K | 4.6% |
Award(A) | 28 | $0 | 0.0% |
Other(J) | 90 | $0 | 0.0% |
Insider selling pressure at CEN BIOTECH INC has increased, with 10 insiders executing 135 transactions across all time. Total sales of $997.9K significantly outpace purchases of $0, resulting in a net outflow of $997.9K. This selling activity appears largely discretionary, which may warrant closer attention from investors.